- Home
- PNNT vs ZVRA Comparison
PNNT vs ZVRA Comparison
Compare PNNT & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNNT
- ZVRA
- Stock Information
- Founded
- PNNT 2007
- ZVRA 2006
- Country
- PNNT United States
- ZVRA United States
- Employees
- PNNT N/A
- ZVRA N/A
- Industry
- PNNT Finance: Consumer Services
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- PNNT Finance
- ZVRA Health Care
- Exchange
- PNNT Nasdaq
- ZVRA Nasdaq
- Market Cap
- PNNT 459.4M
- ZVRA 419.5M
- IPO Year
- PNNT 2007
- ZVRA 2015
- Fundamental
- Price
- PNNT $7.17
- ZVRA $7.69
- Analyst Decision
- PNNT Hold
- ZVRA Strong Buy
- Analyst Count
- PNNT 2
- ZVRA 7
- Target Price
- PNNT $6.00
- ZVRA $21.20
- AVG Volume (30 Days)
- PNNT 436.5K
- ZVRA 380.4K
- Earning Date
- PNNT 02-10-2025
- ZVRA 03-27-2025
- Dividend Yield
- PNNT 12.97%
- ZVRA N/A
- EPS Growth
- PNNT 11.30
- ZVRA N/A
- EPS
- PNNT 0.83
- ZVRA N/A
- Revenue
- PNNT $143,689,000.00
- ZVRA $24,489,000.00
- Revenue This Year
- PNNT N/A
- ZVRA N/A
- Revenue Next Year
- PNNT N/A
- ZVRA $330.04
- P/E Ratio
- PNNT $8.62
- ZVRA N/A
- Revenue Growth
- PNNT N/A
- ZVRA 47.85
- 52 Week Low
- PNNT $6.43
- ZVRA $4.20
- 52 Week High
- PNNT $8.04
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- PNNT 54.56
- ZVRA 48.77
- Support Level
- PNNT $7.10
- ZVRA $7.64
- Resistance Level
- PNNT $7.25
- ZVRA $8.21
- Average True Range (ATR)
- PNNT 0.09
- ZVRA 0.29
- MACD
- PNNT 0.00
- ZVRA 0.03
- Stochastic Oscillator
- PNNT 70.69
- ZVRA 57.93
About PNNT PennantPark Investment Corporation
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.